For very early prediction, previous studies did not find any standard clinical biomarkers to help predict the severity of CRS, because many patients’ clinical biomarkers (such as IL-6, LDH, CRP, ferritin, among others) reached their peak after illness. This evidence concerns the gene IL6 and congenital rubella syndrome.